Related Experiment Video
Updated: Jul 14, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity
1Vascular Biology Group, Division of Neonatology, Department of Pediatrics, University of Alberta, Edmonton, Alta., Canada. bthebaud@ualberta.ca
Insights
Bronchopulmonary dysplasia (BPD) now affects premature infants with arrested alveolar development. Angiogenic growth factors, particularly vascular endothelial growth factor, play a key role in lung development and repair, offering therapeutic targets.
Area of Science:
- Neonatal medicine
- Pulmonary biology
- Developmental biology
Background:
- Bronchopulmonary dysplasia (BPD) remains a challenge despite advances in perinatal care.
- Modern BPD affects extremely premature infants, characterized by arrested alveolar development.
- Signaling mechanisms regulating lung development, especially alveolar and vascular growth, are not fully understood.
Purpose of the Study:
- To review the role of angiogenic growth factors in normal alveolar development.
- To explore the involvement of these factors in lung injury and repair processes.
- To highlight the significance of vascular endothelial growth factor (VEGF) in BPD.
Main Methods:
- Literature review focusing on recent research in lung development and BPD.
- Analysis of signaling pathways involved in alveolar and capillary network formation.
- Emphasis on the role of vascular endothelial growth factor (VEGF) and related pathways.
Main Results:
- Normal alveolar and capillary development is regulated by complex signaling pathways.
- Angiogenic factors, including VEGF, are crucial for both normal lung development and repair after injury.
- Disruption of these pathways contributes to the pathogenesis of BPD in preterm infants.
Conclusions:
- Understanding angiogenic factor roles is critical for developing novel BPD therapies.
- Targeting VEGF signaling may offer a promising strategy for treating lung diseases with alveolar damage.
- Further research into these mechanisms is needed to improve outcomes for premature infants.
Abstract:
Since the initial description of bronchopulmonary dysplasia (BPD) 40 years ago, advances in perinatal care have allowed the survival of infants that are more immature. The disease has not disappeared, but it now affects infants with undeveloped distal airspaces, resulting in an arrest of alveolar development. The histological changes that occur during normal lung development are well described, but little is known about the signaling mechanisms that regulate saccular and alveolar development. Understanding how alveoli and the underlying capillary network develop and how these mechanisms are disrupted in preterm infants with BPD is critical to develop efficient and effective therapies for lung diseases characterized by alveolar damage. This brief review focuses on the recently recognized role of angiogenic growth factors during normal alveolar development, injury and repair with a particular emphasis on the vascular endothelial growth factor.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Mechanism of Angiogenesis
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

